COMMUNIQUÉS West-GlobeNewswire

Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical Program in Knee Osteoarthritis
02/05/2019
Pivotal STRIDES trials to be conducted to support lorecivivint as a potential disease-modifying treatment for knee osteoarthritis First patient dosing is anticipated in the second quarter of 2019 SAN DIEGO, May 02, 2019 [...]
PhaseBio To Report First Quarter 2019 Financial Results and Recent Corporate Progress on May 9, 2019
02/05/2019
MALVERN, Pa. and SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Chipmunk Health chooses Philips HealthSuite digital platform to roll out and scale up its telehealth services
02/05/2019
May 1, 2019 Powered by Philips’ HealthSuite digital platform, new General Practitioner telehealth service from Chipmunk Health aims to forge a closer and more effective relationship between patients and their doctors [...]
Release date of three-month interim report 2019 for ALK and audio cast
02/05/2019
On Thursday, 9 May 2019, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its three-month interim report 2019. ALK will host a meeting for analysts and institutional investors that day at 13.30 p.m. (CEST) at which [...]
So-Young Announces Pricing of Initial Public Offering
02/05/2019
BEIJING, May 02, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
LIDDS develops its own proprietary product for intratumoral immunotherapy - Freedom to operate analysis done for the TLR9-agonist project
02/05/2019
LIDDS has an ongoing preclinical development program based on a clinical stage TLR9 agonist. The objective is to use a NanoZolid® formulation with the TLR9 agonist as an intratumoral immunotherapy in combination with [...]
First patient treated with C-RAD’s cutting-edge positioning system at the Cancer Care Center Negrar-Verona, Italy
02/05/2019
C-RAD and Ospedale Sacro Cuore Don Calabria – the Cancer Care Center in Negrar-Verona - announced today that the first patient has been treated with C-RAD’s surface tracking system at the site. In Italy, the [...]
Statement re Cancellation
02/05/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION Certain information contained [...]
Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION
02/05/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 2 May 2019, 08:00 CEST BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION Mechelen, Belgium, 2 May 2019 - Biocartis Group NV ("Biocartis" or the " [...]
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018
02/05/2019
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018 Paris, le 2 mai 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, [...]
AroCell expands its distribution network and signs distribution agreement with Inveniolife
02/05/2019
AroCell AB (publ) announce today that a distribution agreement has been signed with the Mumbai based company Inveniolife Technology Pvt. Ltd. for the promotion and distribution of the AroCell TK 210™ ELISA in India. [...]
DBV Technologies to Attend Upcoming Investor Conferences
02/05/2019
Montrouge, France, May 2, 2019 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
02/05/2019
Montrouge, France, le 2 mai (7H30 CET), 2019 DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs DBV Technologies (Euronext: DBV – ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une [...]
Basilea's partner Avir Pharma has launched antifungal Cresemba® (isavuconazole) in Canada
02/05/2019
Basel, Switzerland, May 02, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Avir Pharma Inc. (“Avir Pharma”) has launched the antifungal Cresemba ® (isavuconazole) in Canada. David Veitch [...]
VALNEVA Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones
02/05/2019
Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones Repeated significant growth in IXIARO ® revenues; Lyme disease and chikungunya programs advancing towards major [...]
VALNEVA : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D
02/05/2019
Valneva : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D Croissance significative et répétée des ventes d'IXIARO ® ; Avancée des programmes contre la maladie [...]
Lloyd Diamond will serve as Chief Executive Officer of Pixium Vision
02/05/2019
Paris, May 2 nd , 2019 – 07:00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent [...]
Lloyd Diamond sera nommé Directeur Général de Pixium Vision
02/05/2019
Paris, 2 mai 2019 – 07 : 00 CEST - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
Genkyotex Reports Clinical Evidence of Anti-fibrotic Activity by GKT831 in Liver Fibrosis Patients
02/05/2019
Top Line Efficacy Results from Phase 2 Primary Biliary Cholangitis (PBC) Trial 22% reduction in liver stiffness in PBC patients with liver fibrosis compared to a 4% increase for placebo (p=0.038), supports anti-fibrotic [...]

Pages